TY - JOUR
T1 - Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation
T2 - a Japanese multicenter registry substudy
AU - for the SAKURA AF Registry Investigators
AU - Kuronuma, Keiichiro
AU - Okumura, Yasuo
AU - Yokoyama, Katsuaki
AU - Matsumoto, Naoya
AU - Tachibana, Eizo
AU - Oiwa, Koji
AU - Matsumoto, Michiaki
AU - Kojima, Toshiaki
AU - Haruta, Hironori
AU - Nomoto, Kazumiki
AU - Sonoda, Kazumasa
AU - Arima, Ken
AU - Kogawa, Rikitake
AU - Takahashi, Fumiyuki
AU - Kotani, Tomobumi
AU - Okubo, Kimie
AU - Fukushima, Seiji
AU - Itou, Satoru
AU - Kondo, Kunio
AU - Chiku, Masaaki
AU - Ohno, Yasumi
AU - Onikura, Motoyuki
AU - Hirayama, Atsushi
N1 - Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/11/2
Y1 - 2019/11/2
N2 - Objective: To explore factors related to changing renal function and the prognostic effect of worsening renal function in patients with atrial fibrillation (AF). Methods: The present substudy was based on the SAKURA AF Registry, a Japanese multicenter prospective observational registry that includes 3267 AF patients from 63 institutions in the Tokyo area. Worsening renal function was defined as an estimated glomerular filtration rate (eGFR) decrease equaling more than 20% of the patient’s baseline eGFR. Results: During a median 39.3 month follow-up period, patients’ eGFR decreased annually by a mean value of 1.07 mL/min/1.73 m2. Multivariable analysis showed that age ≥75 years, body weight ≤50 kg, a history of heart failure and initially preserved renal function (creatinine clearance [CrCl] ≥ 60 mL/min) were significantly associated with a decrease in eGFR, whereas a history of AF ablation was associated with a maintain in eGFR. The 194 patients with worsening renal function were at significantly increased risk of death, stroke and major bleeding (adjusted hazard ratios [HRs]: 2.06, 1.97 and 2.23, respectively). Conclusion: Age ≥75 years, body weight ≤50 kg, a history of heart failure and initially preserved renal function appear to promote renal dysfunction in patients with AF, but a history of AF ablation seems to have a favorable effect. Worsening renal function seems to increase AF patients’ risk of adverse clinical events. Renal function can decline quickly; thus, early intervention including AF ablation is warranted.
AB - Objective: To explore factors related to changing renal function and the prognostic effect of worsening renal function in patients with atrial fibrillation (AF). Methods: The present substudy was based on the SAKURA AF Registry, a Japanese multicenter prospective observational registry that includes 3267 AF patients from 63 institutions in the Tokyo area. Worsening renal function was defined as an estimated glomerular filtration rate (eGFR) decrease equaling more than 20% of the patient’s baseline eGFR. Results: During a median 39.3 month follow-up period, patients’ eGFR decreased annually by a mean value of 1.07 mL/min/1.73 m2. Multivariable analysis showed that age ≥75 years, body weight ≤50 kg, a history of heart failure and initially preserved renal function (creatinine clearance [CrCl] ≥ 60 mL/min) were significantly associated with a decrease in eGFR, whereas a history of AF ablation was associated with a maintain in eGFR. The 194 patients with worsening renal function were at significantly increased risk of death, stroke and major bleeding (adjusted hazard ratios [HRs]: 2.06, 1.97 and 2.23, respectively). Conclusion: Age ≥75 years, body weight ≤50 kg, a history of heart failure and initially preserved renal function appear to promote renal dysfunction in patients with AF, but a history of AF ablation seems to have a favorable effect. Worsening renal function seems to increase AF patients’ risk of adverse clinical events. Renal function can decline quickly; thus, early intervention including AF ablation is warranted.
KW - Adverse clinical events
KW - Japanese
KW - atrial fibrillation
KW - registry
KW - worsening renal function
UR - http://www.scopus.com/inward/record.url?scp=85073579266&partnerID=8YFLogxK
U2 - 10.1080/03007995.2019.1631597
DO - 10.1080/03007995.2019.1631597
M3 - Article
C2 - 31204852
AN - SCOPUS:85073579266
SN - 0300-7995
VL - 35
SP - 2007
EP - 2013
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 11
ER -